Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study-group on Palliative ERCP And RFA-ablation in Metastatic and Inoperable Pancreatic Tumors

NCT07191418 is registered in ClinicalTrials.gov with Roberto Valente as lead sponsor.

NCT NCT07191418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07191418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study-group on Palliative ERCP And RFA-ablation in Metastatic and Inoperable Pancreatic Tumors
Lead sponsor
Roberto Valente
Phase
Not applicable
Overall status
Recruiting
Start date
April 9, 2026
Completion date
September 30, 2027
Enrollment
178 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer metastatic to liver